PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Nonoxinol 9
Presentation Product Chemical substance Chapter Items dispensed
Gygel 2% contraceptive jelly
0703030G0BMAAAI
Gygel Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders 62
Nonoxinol-9 2% gel
0703030G0AAAIAI
Nonoxinol 9 Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders 49
Delfen 12.5% contraceptive foam
0703030G0BCABAE
Delfen Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Duragel 2% gel
0703030G0BKAAAI
Duragel Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Gynol-II 2% contraceptive jelly
0703030G0BEAAAI
Gynol-II Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Nonoxinol-9 12.5% vaginal foam aerosol
0703030G0AAAEAE
Nonoxinol 9 Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Nonoxinol-9 2% cream
0703030G0AAABAB
Nonoxinol 9 Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Nonoxinol-9 5% pessaries
0703030G0AAAHAH
Nonoxinol 9 Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Nonoxinol-9 6% pessaries
0703030G0AAAGAG
Nonoxinol 9 Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Ortho-Creme 2% contraceptive cream
0703030G0BFAAAB
Ortho-Creme Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Orthoforms 5% contraceptive pessaries
0703030G0BGAAAH
Ortho-Forms Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Prelude 6% pessaries
0703030G0BLAAAG
Prelude Nonoxinol 9 Obstetrics, Gynaecology and Urinary-Tract Disorders No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.